REGENXBIO Inc.
$644.27M- Market cap
- $590.16M
- Debt
- +$284.18M
- Cash
- −$230.07M
Capital structure 67% equity / 33% debt · EV / Revenue 3.78x
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2025 · Mkt capMarket cap $590.16M · View financials
Snapshot Sep 4, 4:00 PM ET
FY 2026 ·
Decision snapshot: RGNX stock price at premium vs WWW $8.94 current versus $2.35 implied using P/S multiple.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at WWW's multiple
Implied fair value · at RGNX's multiple
Snapshot Sep 4, 4:00 PM ET
Metric by metric
Where each company leads, and how wide the gap is.
Growth edge
Pricing power
Operating leverage
Multiple premium
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: RGNX FY 2025 (ended Dec 31, 2025) · WWW FY 2026 (ended Jan 3, 2026). Fiscal years are not aligned.
Trendline
Six fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Capital structure 67% equity / 33% debt · EV / Revenue 3.78x
Complete market value, debt and cash evidence is required for enterprise value.
Capital structure 73% equity / 27% debt
WWW carries the larger enterprise value at $2.33B against $644.27M; WWW trades on the lower EV / Revenue multiple (1.24x vs 3.78x).
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
REGENXBIO Inc. · implied price per share
Latest annual free cash flow must be positive to qualify the filing-backed baseline.
WOLVERINE WORLD WIDE, INC. · implied price per share
Five annual free-cash-flow observations are required for the filing-backed baseline.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Debt / equity
Total debt against shareholders' equity
2.77x
1.52x
Net debt / EBITDA
Leverage against operating earnings
-0.28x
—
Cash and equivalents
Liquid reserves on the balance sheet
$230.07M
—
Total debt
Interest-bearing obligations outstanding
$284.18M
$621.70M
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.